FDA

20/09/2021
Política The New York Times - Estados Unidos Política

Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says

12:34 - Vaccinated kids aged 5 to 11 showed evidence of protection against the virus, the company said. The data must be reviewed by the F.D.A. before children can be inoculated.
02/08/2021
Política Bloomberg - Estados Unidos Política Robert Langreth

‘Very Real Fourth Wave’ Presses FDA to Fully Approve Covid Shots

18:19 - Agency also looking at international data as it weighs booster doses, vaccine chief Marks says
12/07/2021
Política El País - España Política

La agencia del medicamento de EE UU advierte de un nuevo efecto secundario muy infrecuente de la vacuna de Johnson & Johnson

16:09 - La administración del fármaco está relacionada con un centenar de casos de una rara enfermedad neurológica entre casi 13 millones de pinchazos
11/06/2021
Política The Wall Street Journal - Estados Unidos Política

FDA Approves Export of Covid-19 Vaccine Doses From Troubled Baltimore Plant

16:24 - The agency said 10 million doses can be exported, but 60 million doses were at risk of contamination and can’t be used.
03/05/2021
Política Daily Mail - Reino Unido Política

FDA expected to authorize Pfizer's Covid vaccine for teens ages 12-15 by next WEEK

19:08 - U.S. regulators are expected green light Pfizer's Covid vaccine to be given to teenagers between ages 12 and 15 as early as the end of this week, officials told the New York Times.
17/12/2020
Política Bloomberg - Estados Unidos Política Internacional

FDA Advisers Back Moderna Vaccine, Putting Second Shot in Reach

19:02 - Moderna Inc.’s Covid-19 vaccine won backing from a panel of experts who advise U.S. regulators, setting the stage for its shot to be the second vaccine cleared in the U.S. in as many weeks.
16/12/2020
Política La Política Online - México Salud

La FDA determinó que la vacuna de Moderna es efectiva y la autorizará esta semana

El organismo regulador de EU dictaminó que la eficacia de la vacuna fue del 94,5%. El canciller Ebrard confirmó negociaciones para recibir la vacuna.
www.prensa.cancilleria.gob.ar es un sitio web oficial del Gobierno Argentino